G
o
o
g
l
e
All
Shopping
Images
News
Maps
Videos
Books
Search tools
Archives
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by date
Sorted by relevance
Sorted by date
Clear
Study offers a potential pathway for safer, non-addictive pain management
MSN
Researchers from the National University of Singapore (NUS), in collaboration with Peking University, China, have made a discovery regarding the TRPV1...
5 days ago
Non-addictive pain killer could soon be FDA-approved
Audacy
Doctors and researchers have long searched for a non-opioid answer to pain and now, the FDA could approve a pill that claims to take away the pain without...
1 week ago
Billed as nonaddictive, new pain pill could soon win FDA approval
The Washington Post
Questions remain about whether the non-opioid drug developed by Vertex Pharmaceuticals could be effective for chronic pain. January 13, 2025.
1 week ago
Non-addictive pain relief hope in breakthrough brain study by IISc scientists
Telegraph India
Scientists have known for decades that the brain has the capacity to spontaneously increase pain thresholds, allowing athletes, for instance,...
2 weeks ago
Goodbye to pain, scientists discover a safe and non-addictive way to combat it
Marca.com
Recently, a team of researchers has made a significant discovery that could transform the way pain relief is approached. According to an article published...
3 weeks ago
Researchers develop safer, non-addictive approach for pain relief
Sharjah24
Researchers from the National University of Singapore (NUS) and Chinas Peking University have discovered how solvent molecules, particularly deuterated...
3 weeks ago
Breakthrough in Pain Relief: Scientists Unveil a Safer, Non-Addictive Approach
SciTechDaily
Researchers from NUS and Peking University have discovered how solvent molecules, particularly deuterated water (D₂O), modulate the TRPV1 ion channel to...
3 weeks ago
SiteOne Therapeutics, a pain biotech that’s partnered with Vertex, nabs $100M
Endpoints News
About eight years after its Series B, a small biotech working on non-opioid treatments has raised its Series C to gather clinical proof of concept in acute...
1 month ago
A Vertex partner — and potential rival — secures $100M to develop non-opioid pain drugs
BioPharma Dive
SiteOne Therapeutics was passed over by investors for years. Now, it has backing from Novo Holdings and others, and plans to use the cash to obtain “proof of...
1 month ago
Breakthrough Study: Natural Compound Could Counter Opioid Addiction Without Sacrificing Pain Relief
SciTechDaily
Boosting the endocannabinoid 2-AG in the brain can counteract opioid addiction while preserving their pain relief, a Weill Cornell Medicine study finds.
1 month ago